Nuvectis Pharma (NVCT) had priced its underwritten public offering of 5M shares of its common stock at $20 per share, with expected gross proceeds of $100M, the company said Monday, sending shares down 19% in after-market trading. Nuvectis has also granted Source link
Up 50% in a year! That’s not the only reason I’d consider buying Barclays over Nvidia stock today
Investors love Nvidia (NASDAQ: NVDA) and with good reason. The shares are up a stunning 840% in the last five years. I hold a small position myself, and only wish I’d bought more. This is the ultimate picks-and-shovels stock, selling the chips and infrastructure that power the artificial intelligence boom.…
AeroVironment projects $2.125B-$2.225B FY2027 revenue while expanding manufacturing capacity (NASDAQ:AVAV)
Earnings Call Insights: AeroVironment (AVAV) Q4 fiscal year 2026 Management view “We reported fourth quarter revenues of nearly $642 million with increased funded backlog of $1.2 billion, strong adjusted EBITDA of $140 million and bookings of $572 million.” (Chairman of the Board, President & CEO Wahid Nawabi) Seeking Alpha’s Disclaimer:…
U.S. may face blackouts by next year due to power supply shortfall, Exelon CEO warns (EXC:NASDAQ)
peterschreiber.media/iStock via Getty Images The U.S. could face power blackouts as soon as 2027 due to the strain on the grid from growing electricity demand, and higher power bills are needed to fund new infrastructure, Exelon (EXC) CEO Calvin Butler told the Source link
Concentrix targets $630M-$650M FY2026 adjusted free cash flow while aiming to surpass $120M iX Suite ARR (NASDAQ:CNXC)
Earnings Call Insights: Concentrix (CNXC) Q2 2026 Management View “Our second quarter marked an acceleration in many areas in the evolution of our business” including “record level of contract signings for our iX Suite of technology, up 400% year-over-year for the number of deals” and “a Seeking Alpha’s Disclaimer: This…
Securitize heads to NYSE debut after investors approve SPAC merger; CEPT gains 20%
Securitize, a tokenization specialist backed by BlackRock, said Monday it cleared a final major hurdle to becoming a public company after shareholders of Cantor Equity Partners II (CEPT) approved the firms’ proposed merger on Monday. The transaction is expected to close on Wednesday, subject to customary closing conditions, with the…
Writing an Impactful Resume (for Felons)
By Jeff Altman, The Big Game Hunter For individuals with a felony conviction, finding employment can be a significant challenge. However, a well-crafted resume can be a powerful tool in overcoming these obstacles and increasing your chances of securing a job opportunity. Your resume is often the first impression an…
AbbVie touts phase 3 results for Epkinly in 2L large B-cell lymphoma (ABBV:NYSE)
Nemes Laszlo/iStock via Getty Images AbbVie (ABBV) said that its experimental T-cell engaging bispecific antibody Epkinly (epcoritamab) in combination with Revlimid (lenalidomide) led to better progression-free survival in large B-cell lymphoma patients who had failed on at least one prior therapy compared to those on a regimen Source link
Gold turns lower as U.S.-Iran tensions ratchet up, but Goldman says 'gold is not done'
Gold turns lower as U.S.-Iran tensions ratchet up, but Goldman says 'gold is not done' Source link
Charter gains on report of SpaceX talks, but wireless threat may be overstated: BNP Paribas
Charter gains on report of SpaceX talks, but wireless threat may be overstated: BNP Paribas Source link